Aarti Drugs’ CFO Adhish P. Patil Elevated To MD As Prakash M. Patil Retires
Aarti Drugs Limited has announced a leadership transition, with Adhish P. Patil elevated from Chief Financial Officer (CFO) to Managing Director (MD) with effect from October 1, 2026. The appointment was approved by shareholders at the company’s Annual General Meeting held on September 26, 2026.
The elevation follows the early retirement of Prakash M. Patil, who has stepped down as Chairman, MD and Chief Executive Officer (CEO) of Aarti Drugs with effect from September 30, 2026. With his appointment as MD, Adhish P. Patil has relinquished his position as Chief Financial Officer with effect from September 30, 2026.
Patil has 18 years of experience. He was recognised among the ‘Top 100 CFOs India 2014’ and was also included in StartupLanes’ ‘Top 200 CFOs in India’ list in 2023. During his career, he has managed production efficiencies, projects, financial operations, ERP implementation and automation initiatives supporting regulatory compliance for a publicly listed pharmaceutical company. He holds a Bachelor of Engineering in Information Technology from the University of Mumbai and an MBA in Finance and Marketing from the University of Florida’s Warrington College of Business Administration, where he was a gold medallist.




